G04C Drugs used in benign prostatic hypertrophy Drogas usadas en la hipertrofia prostática benigna Drugs used in benign prostatic hypertrophy Drugs used in benign prostatic hypertrophy L3
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L3 · Search this class · Consumer categories
Child classes
G04CAAlpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonistsG04CBTestosterone-5-alpha reductase inhibitors Testosterone-5-alpha reductase inhibitors Testosterone-5-alpha reductase inhibitors Testosterone-5-alpha reductase inhibitorsG04CXOther drugs used in benign prostatic hypertrophy Other drugs used in benign prostatic hypertrophy Other drugs used in benign prostatic hypertrophy Other drugs used in benign prostatic hypertrophy
Active ingredients in this class
10 active ingredients 10 principios activos 10 个活性成分 10 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Finasteride
G04CB01active US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN ES MX TW FR · unknown AU HK - Tamsulosin
G04CA02Salt form: Tamsulosin Hydrochloride
Tamsulosin Hydrochlorideactive US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW FR · unknown HK - Dutasteride
G04CB02active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG CN ES MX TW FR · unknown HK - Alfuzosin
G04CA01Salt form: Alfuzosin Hydrochloride
Alfuzosin Hydrochlorideactive US GB CA SG CN · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA SG CN ES MX TW FR · unknown AU HK - Terazosin
G04CA03active US GB CA SG CN · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA SG CN ES TW FR · unknown MX HK - Silodosin
G04CA04active US GB CA CN ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA CN ES TW EU FR · unknown AU HK - Serenoa Repens
G04CX02active AU ES FR
active AU ES FR - 普适泰
G04CXactive CN
active CN - 爱普列特
G04CBactive CN
active CN - 蓝棕果
G04CXactive CN
active CN
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.